nodes	percent_of_prediction	percent_of_DWPC	metapath
Fludarabine—RRM1—Nucleotide Metabolism—POLD1—uterine cancer	0.0153	0.0556	CbGpPWpGaD
Fludarabine—RRM1—Synthesis and interconversion of nucleotide di- and triphosphates—RRM2—uterine cancer	0.0133	0.0484	CbGpPWpGaD
Fludarabine—RRM1—Nucleotide Metabolism—RRM2—uterine cancer	0.0127	0.0464	CbGpPWpGaD
Fludarabine—POLA1—Removal of the Flap Intermediate—POLD1—uterine cancer	0.011	0.04	CbGpPWpGaD
Fludarabine—POLA1—Leading Strand Synthesis—POLD1—uterine cancer	0.011	0.04	CbGpPWpGaD
Fludarabine—POLA1—myometrium—uterine cancer	0.0106	0.0452	CbGeAlD
Fludarabine—SLC28A3—mammalian vulva—uterine cancer	0.0103	0.0438	CbGeAlD
Fludarabine—POLA1—Processive synthesis on the lagging strand—POLD1—uterine cancer	0.00987	0.0359	CbGpPWpGaD
Fludarabine—POLA1—Nucleotide Metabolism—POLD1—uterine cancer	0.0086	0.0313	CbGpPWpGaD
Fludarabine—RRM1—myometrium—uterine cancer	0.00844	0.0359	CbGeAlD
Fludarabine—POLA1—uterine cervix—uterine cancer	0.00827	0.0352	CbGeAlD
Fludarabine—RRM1—Fluoropyrimidine Activity—RRM2—uterine cancer	0.00819	0.0298	CbGpPWpGaD
Fludarabine—SLC28A3—female gonad—uterine cancer	0.00803	0.0342	CbGeAlD
Fludarabine—POLA1—Lagging Strand Synthesis—POLD1—uterine cancer	0.00794	0.0289	CbGpPWpGaD
Fludarabine—Cytarabine—POLD1—uterine cancer	0.0079	0.378	CrCbGaD
Fludarabine—POLA1—decidua—uterine cancer	0.00788	0.0335	CbGeAlD
Fludarabine—POLA1—G1/S-Specific Transcription—RRM2—uterine cancer	0.00784	0.0285	CbGpPWpGaD
Fludarabine—SLC29A1—Fluoropyrimidine Activity—RRM2—uterine cancer	0.00749	0.0273	CbGpPWpGaD
Fludarabine—POLA1—endometrium—uterine cancer	0.00748	0.0318	CbGeAlD
Fludarabine—POLA1—Telomere C-strand (Lagging Strand) Synthesis—POLD1—uterine cancer	0.00739	0.0269	CbGpPWpGaD
Fludarabine—POLA1—mammalian vulva—uterine cancer	0.00724	0.0308	CbGeAlD
Fludarabine—POLA1—Nucleotide Metabolism—RRM2—uterine cancer	0.00717	0.0261	CbGpPWpGaD
Fludarabine—SLC29A1—myometrium—uterine cancer	0.00686	0.0292	CbGeAlD
Fludarabine—RRM1—uterine cervix—uterine cancer	0.00657	0.0279	CbGeAlD
Fludarabine—DCK—myometrium—uterine cancer	0.00655	0.0279	CbGeAlD
Fludarabine—RRM1—smooth muscle tissue—uterine cancer	0.00638	0.0272	CbGeAlD
Fludarabine—RRM1—decidua—uterine cancer	0.00626	0.0266	CbGeAlD
Fludarabine—RRM1—renal system—uterine cancer	0.00614	0.0261	CbGeAlD
Fludarabine—POLA1—Extension of Telomeres—POLD1—uterine cancer	0.00614	0.0223	CbGpPWpGaD
Fludarabine—RRM1—endometrium—uterine cancer	0.00594	0.0253	CbGeAlD
Fludarabine—RRM1—mammalian vulva—uterine cancer	0.00574	0.0244	CbGeAlD
Fludarabine—POLA1—DNA strand elongation—POLD1—uterine cancer	0.00567	0.0206	CbGpPWpGaD
Fludarabine—POLA1—female gonad—uterine cancer	0.00564	0.024	CbGeAlD
Fludarabine—POLA1—vagina—uterine cancer	0.00561	0.0239	CbGeAlD
Fludarabine—RRM1—uterus—uterine cancer	0.00547	0.0233	CbGeAlD
Fludarabine—SLC29A1—uterine cervix—uterine cancer	0.00534	0.0227	CbGeAlD
Fludarabine—DCK—uterine cervix—uterine cancer	0.0051	0.0217	CbGeAlD
Fludarabine—SLC29A1—decidua—uterine cancer	0.00509	0.0216	CbGeAlD
Fludarabine—Clofarabine—RRM2—uterine cancer	0.00504	0.241	CrCbGaD
Fludarabine—SLC29A1—renal system—uterine cancer	0.00499	0.0213	CbGeAlD
Fludarabine—RRM1—female reproductive system—uterine cancer	0.00492	0.0209	CbGeAlD
Fludarabine—DCK—decidua—uterine cancer	0.00486	0.0207	CbGeAlD
Fludarabine—SLC29A1—endometrium—uterine cancer	0.00483	0.0205	CbGeAlD
Fludarabine—SLC29A1—mammalian vulva—uterine cancer	0.00467	0.0199	CbGeAlD
Fludarabine—DCK—endometrium—uterine cancer	0.00461	0.0196	CbGeAlD
Fludarabine—POLA1—E2F mediated regulation of DNA replication—RRM2—uterine cancer	0.00461	0.0168	CbGpPWpGaD
Fludarabine—RRM1—Retinoblastoma (RB) in Cancer—MSH6—uterine cancer	0.00458	0.0167	CbGpPWpGaD
Fludarabine—POLA1—DNA Replication—POLD1—uterine cancer	0.00456	0.0166	CbGpPWpGaD
Fludarabine—RRM1—Integrated Pancreatic Cancer Pathway—MAP3K4—uterine cancer	0.00448	0.0163	CbGpPWpGaD
Fludarabine—RRM1—female gonad—uterine cancer	0.00448	0.019	CbGeAlD
Fludarabine—DCK—mammalian vulva—uterine cancer	0.00446	0.019	CbGeAlD
Fludarabine—SLC29A1—uterus—uterine cancer	0.00445	0.0189	CbGeAlD
Fludarabine—RRM1—vagina—uterine cancer	0.00445	0.0189	CbGeAlD
Fludarabine—RRM1—E2F transcription factor network—RRM2—uterine cancer	0.00434	0.0158	CbGpPWpGaD
Fludarabine—DCK—uterus—uterine cancer	0.00425	0.0181	CbGeAlD
Fludarabine—RRM1—Fluoropyrimidine Activity—MTHFR—uterine cancer	0.00414	0.0151	CbGpPWpGaD
Fludarabine—RRM1—Nucleotide metabolism—RRM2—uterine cancer	0.00412	0.015	CbGpPWpGaD
Fludarabine—SLC29A1—female reproductive system—uterine cancer	0.004	0.017	CbGeAlD
Fludarabine—POLA1—Norethindrone—Progesterone—uterine cancer	0.00398	0.332	CbGdCrCtD
Fludarabine—DCK—female reproductive system—uterine cancer	0.00382	0.0163	CbGeAlD
Fludarabine—SLC29A1—Fluoropyrimidine Activity—MTHFR—uterine cancer	0.00379	0.0138	CbGpPWpGaD
Fludarabine—RRM1—Retinoblastoma (RB) in Cancer—RRM2—uterine cancer	0.00377	0.0137	CbGpPWpGaD
Fludarabine—SLC29A1—female gonad—uterine cancer	0.00364	0.0155	CbGeAlD
Fludarabine—POLA1—lymph node—uterine cancer	0.00363	0.0154	CbGeAlD
Fludarabine—SLC29A1—vagina—uterine cancer	0.00362	0.0154	CbGeAlD
Fludarabine—DCK—Retinoblastoma (RB) in Cancer—MSH6—uterine cancer	0.00352	0.0128	CbGpPWpGaD
Fludarabine—DCK—female gonad—uterine cancer	0.00348	0.0148	CbGeAlD
Fludarabine—DCK—vagina—uterine cancer	0.00346	0.0147	CbGeAlD
Fludarabine—Adenosine triphosphate—ABCC9—uterine cancer	0.00339	0.162	CrCbGaD
Fludarabine—POLA1—Levonorgestrel—Progesterone—uterine cancer	0.00317	0.264	CbGdCrCtD
Fludarabine—DCK—Nucleotide metabolism—RRM2—uterine cancer	0.00317	0.0115	CbGpPWpGaD
Fludarabine—DCK—Retinoblastoma (RB) in Cancer—RRM2—uterine cancer	0.0029	0.0106	CbGpPWpGaD
Fludarabine—Cladribine—RRM2—uterine cancer	0.00289	0.138	CrCbGaD
Fludarabine—RRM1—lymph node—uterine cancer	0.00288	0.0122	CbGeAlD
Fludarabine—POLA1—Telomere Maintenance—POLD1—uterine cancer	0.00278	0.0101	CbGpPWpGaD
Fludarabine—POLA1—Retinoblastoma (RB) in Cancer—MSH6—uterine cancer	0.00258	0.00939	CbGpPWpGaD
Fludarabine—POLA1—Integrated Pancreatic Cancer Pathway—MAP3K4—uterine cancer	0.00253	0.00919	CbGpPWpGaD
Fludarabine—RRM1—Integrated Pancreatic Cancer Pathway—INHBA—uterine cancer	0.0025	0.00912	CbGpPWpGaD
Fludarabine—POLA1—E2F transcription factor network—RRM2—uterine cancer	0.00244	0.0089	CbGpPWpGaD
Fludarabine—POLA1—Synthesis of DNA—POLD1—uterine cancer	0.00235	0.00857	CbGpPWpGaD
Fludarabine—SLC29A1—lymph node—uterine cancer	0.00234	0.00996	CbGeAlD
Fludarabine—POLA1—Chromosome Maintenance—POLD1—uterine cancer	0.00232	0.00843	CbGpPWpGaD
Fludarabine—DCK—lymph node—uterine cancer	0.00224	0.00951	CbGeAlD
Fludarabine—POLA1—DNA Replication—POLD1—uterine cancer	0.00221	0.00804	CbGpPWpGaD
Fludarabine—POLA1—Retinoblastoma (RB) in Cancer—RRM2—uterine cancer	0.00212	0.00773	CbGpPWpGaD
Fludarabine—POLA1—S Phase—POLD1—uterine cancer	0.00193	0.00703	CbGpPWpGaD
Fludarabine—DCK—Doxorubicin—Epirubicin—uterine cancer	0.00185	0.154	CbGdCrCtD
Fludarabine—POLA1—G1/S Transition—RRM2—uterine cancer	0.00177	0.00646	CbGpPWpGaD
Fludarabine—DCK—Epirubicin—Doxorubicin—uterine cancer	0.00171	0.142	CbGdCrCtD
Fludarabine—Adenosine triphosphate—AKT1—uterine cancer	0.00168	0.0803	CrCbGaD
Fludarabine—RRM1—Integrated Pancreatic Cancer Pathway—EZH2—uterine cancer	0.00161	0.00585	CbGpPWpGaD
Fludarabine—RRM1—Fluoropyrimidine Activity—TP53—uterine cancer	0.00157	0.00572	CbGpPWpGaD
Fludarabine—RRM1—E2F transcription factor network—CDKN2A—uterine cancer	0.0015	0.00545	CbGpPWpGaD
Fludarabine—SLC28A3—Transmembrane transport of small molecules—ABCC9—uterine cancer	0.0015	0.00545	CbGpPWpGaD
Fludarabine—POLA1—Mitotic G1-G1/S phases—RRM2—uterine cancer	0.00149	0.00544	CbGpPWpGaD
Fludarabine—RRM1—Integrated Pancreatic Cancer Pathway—ESR2—uterine cancer	0.00149	0.00542	CbGpPWpGaD
Fludarabine—SLC29A1—Fluoropyrimidine Activity—TP53—uterine cancer	0.00144	0.00523	CbGpPWpGaD
Fludarabine—POLA1—Integrated Pancreatic Cancer Pathway—INHBA—uterine cancer	0.00141	0.00514	CbGpPWpGaD
Fludarabine—RRM1—Integrated Pancreatic Cancer Pathway—STK11—uterine cancer	0.00135	0.00492	CbGpPWpGaD
Fludarabine—RRM1—E2F transcription factor network—CDKN1B—uterine cancer	0.00133	0.00483	CbGpPWpGaD
Fludarabine—DCK—Levonorgestrel—Progesterone—uterine cancer	0.00131	0.109	CbGdCrCtD
Fludarabine—RRM1—Integrated Pancreatic Cancer Pathway—CDKN2B—uterine cancer	0.00121	0.00441	CbGpPWpGaD
Fludarabine—RRM1—E2F transcription factor network—EP300—uterine cancer	0.00116	0.00424	CbGpPWpGaD
Fludarabine—RRM1—Retinoblastoma (RB) in Cancer—CDKN1B—uterine cancer	0.00115	0.00419	CbGpPWpGaD
Fludarabine—SLC29A1—Transmembrane transport of small molecules—ABCC9—uterine cancer	0.00112	0.00406	CbGpPWpGaD
Fludarabine—POLA1—Mitotic M-M/G1 phases—NDC80—uterine cancer	0.00103	0.00376	CbGpPWpGaD
Fludarabine—POLA1—Cell Cycle—MLH3—uterine cancer	0.000988	0.0036	CbGpPWpGaD
Fludarabine—Blood uric acid increased—Epirubicin—uterine cancer	0.000907	0.00198	CcSEcCtD
Fludarabine—POLA1—Integrated Pancreatic Cancer Pathway—EZH2—uterine cancer	0.000905	0.00329	CbGpPWpGaD
Fludarabine—RRM1—Integrated Pancreatic Cancer Pathway—ESR1—uterine cancer	0.000903	0.00329	CbGpPWpGaD
Fludarabine—POLA1—Mitotic G1-G1/S phases—CDKN2B—uterine cancer	0.000901	0.00328	CbGpPWpGaD
Fludarabine—Paraesthesia—Medroxyprogesterone Acetate—uterine cancer	0.000901	0.00197	CcSEcCtD
Fludarabine—Hypocalcaemia—Doxorubicin—uterine cancer	0.0009	0.00197	CcSEcCtD
Fludarabine—Dyspnoea—Medroxyprogesterone Acetate—uterine cancer	0.000895	0.00196	CcSEcCtD
Fludarabine—Pneumonia—Etoposide—uterine cancer	0.000894	0.00195	CcSEcCtD
Fludarabine—Ill-defined disorder—Dactinomycin—uterine cancer	0.00089	0.00195	CcSEcCtD
Fludarabine—Hyperuricaemia—Doxorubicin—uterine cancer	0.000888	0.00194	CcSEcCtD
Fludarabine—Anaemia—Dactinomycin—uterine cancer	0.000887	0.00194	CcSEcCtD
Fludarabine—DCK—Retinoblastoma (RB) in Cancer—CDKN1B—uterine cancer	0.000886	0.00323	CbGpPWpGaD
Fludarabine—Dyspepsia—Medroxyprogesterone Acetate—uterine cancer	0.000884	0.00193	CcSEcCtD
Fludarabine—Stevens-Johnson syndrome—Etoposide—uterine cancer	0.000881	0.00193	CcSEcCtD
Fludarabine—Acute coronary syndrome—Etoposide—uterine cancer	0.000876	0.00192	CcSEcCtD
Fludarabine—Body temperature increased—Progesterone—uterine cancer	0.000876	0.00191	CcSEcCtD
Fludarabine—Hyperkalaemia—Epirubicin—uterine cancer	0.000875	0.00191	CcSEcCtD
Fludarabine—Renal failure—Etoposide—uterine cancer	0.000873	0.00191	CcSEcCtD
Fludarabine—Decreased appetite—Medroxyprogesterone Acetate—uterine cancer	0.000873	0.00191	CcSEcCtD
Fludarabine—Myocardial infarction—Etoposide—uterine cancer	0.000871	0.0019	CcSEcCtD
Fludarabine—Neuropathy peripheral—Etoposide—uterine cancer	0.000871	0.0019	CcSEcCtD
Fludarabine—Gastrointestinal disorder—Medroxyprogesterone Acetate—uterine cancer	0.000867	0.00189	CcSEcCtD
Fludarabine—Stomatitis—Etoposide—uterine cancer	0.000866	0.00189	CcSEcCtD
Fludarabine—Fatigue—Medroxyprogesterone Acetate—uterine cancer	0.000865	0.00189	CcSEcCtD
Fludarabine—Malaise—Dactinomycin—uterine cancer	0.000865	0.00189	CcSEcCtD
Fludarabine—Leukopenia—Dactinomycin—uterine cancer	0.000859	0.00188	CcSEcCtD
Fludarabine—Constipation—Medroxyprogesterone Acetate—uterine cancer	0.000858	0.00188	CcSEcCtD
Fludarabine—POLA1—E2F transcription factor network—CDKN2A—uterine cancer	0.000843	0.00307	CbGpPWpGaD
Fludarabine—POLA1—Integrated Pancreatic Cancer Pathway—ESR2—uterine cancer	0.000839	0.00305	CbGpPWpGaD
Fludarabine—Blood uric acid increased—Doxorubicin—uterine cancer	0.000839	0.00183	CcSEcCtD
Fludarabine—Feeling abnormal—Medroxyprogesterone Acetate—uterine cancer	0.000827	0.00181	CcSEcCtD
Fludarabine—Myalgia—Dactinomycin—uterine cancer	0.000817	0.00179	CcSEcCtD
Fludarabine—Hypersensitivity—Progesterone—uterine cancer	0.000816	0.00178	CcSEcCtD
Fludarabine—Coma—Epirubicin—uterine cancer	0.000814	0.00178	CcSEcCtD
Fludarabine—Oesophagitis—Epirubicin—uterine cancer	0.000814	0.00178	CcSEcCtD
Fludarabine—Hyperkalaemia—Doxorubicin—uterine cancer	0.000809	0.00177	CcSEcCtD
Fludarabine—Discomfort—Dactinomycin—uterine cancer	0.000807	0.00176	CcSEcCtD
Fludarabine—Asthenia—Progesterone—uterine cancer	0.000795	0.00174	CcSEcCtD
Fludarabine—Hypoaesthesia—Etoposide—uterine cancer	0.000794	0.00174	CcSEcCtD
Fludarabine—Body temperature increased—Medroxyprogesterone Acetate—uterine cancer	0.000793	0.00174	CcSEcCtD
Fludarabine—RRM1—Metabolism—NDUFB11—uterine cancer	0.00079	0.00288	CbGpPWpGaD
Fludarabine—RRM1—Metabolism—SRD5A2—uterine cancer	0.00079	0.00288	CbGpPWpGaD
Fludarabine—Pruritus—Progesterone—uterine cancer	0.000784	0.00171	CcSEcCtD
Fludarabine—Oedema—Dactinomycin—uterine cancer	0.000783	0.00171	CcSEcCtD
Fludarabine—Infection—Dactinomycin—uterine cancer	0.000778	0.0017	CcSEcCtD
Fludarabine—POLA1—Cell Cycle, Mitotic—NDC80—uterine cancer	0.000773	0.00281	CbGpPWpGaD
Fludarabine—Thrombocytopenia—Dactinomycin—uterine cancer	0.000767	0.00168	CcSEcCtD
Fludarabine—POLA1—Integrated Pancreatic Cancer Pathway—STK11—uterine cancer	0.000762	0.00277	CbGpPWpGaD
Fludarabine—Diarrhoea—Progesterone—uterine cancer	0.000758	0.00166	CcSEcCtD
Fludarabine—Erythema multiforme—Etoposide—uterine cancer	0.000754	0.00165	CcSEcCtD
Fludarabine—Coma—Doxorubicin—uterine cancer	0.000753	0.00165	CcSEcCtD
Fludarabine—Oesophagitis—Doxorubicin—uterine cancer	0.000753	0.00165	CcSEcCtD
Fludarabine—Phlebitis—Epirubicin—uterine cancer	0.00075	0.00164	CcSEcCtD
Fludarabine—POLA1—E2F transcription factor network—CDKN1B—uterine cancer	0.000747	0.00272	CbGpPWpGaD
Fludarabine—Anorexia—Dactinomycin—uterine cancer	0.000746	0.00163	CcSEcCtD
Fludarabine—Hypersensitivity—Medroxyprogesterone Acetate—uterine cancer	0.00074	0.00162	CcSEcCtD
Fludarabine—RRM1—Retinoblastoma (RB) in Cancer—TP53—uterine cancer	0.000724	0.00264	CbGpPWpGaD
Fludarabine—Asthenia—Medroxyprogesterone Acetate—uterine cancer	0.00072	0.00157	CcSEcCtD
Fludarabine—Hepatic failure—Epirubicin—uterine cancer	0.000719	0.00157	CcSEcCtD
Fludarabine—Chills—Etoposide—uterine cancer	0.000716	0.00156	CcSEcCtD
Fludarabine—Musculoskeletal discomfort—Dactinomycin—uterine cancer	0.000713	0.00156	CcSEcCtD
Fludarabine—Cardiac failure congestive—Epirubicin—uterine cancer	0.000713	0.00156	CcSEcCtD
Fludarabine—Pruritus—Medroxyprogesterone Acetate—uterine cancer	0.00071	0.00155	CcSEcCtD
Fludarabine—Alopecia—Etoposide—uterine cancer	0.000705	0.00154	CcSEcCtD
Fludarabine—Vomiting—Progesterone—uterine cancer	0.000704	0.00154	CcSEcCtD
Fludarabine—Rash—Progesterone—uterine cancer	0.000698	0.00153	CcSEcCtD
Fludarabine—Dermatitis—Progesterone—uterine cancer	0.000698	0.00153	CcSEcCtD
Fludarabine—Phlebitis—Doxorubicin—uterine cancer	0.000694	0.00152	CcSEcCtD
Fludarabine—Headache—Progesterone—uterine cancer	0.000694	0.00152	CcSEcCtD
Fludarabine—POLA1—Cell Cycle—NDC80—uterine cancer	0.000691	0.00252	CbGpPWpGaD
Fludarabine—Diarrhoea—Medroxyprogesterone Acetate—uterine cancer	0.000687	0.0015	CcSEcCtD
Fludarabine—POLA1—Integrated Pancreatic Cancer Pathway—CDKN2B—uterine cancer	0.000683	0.00249	CbGpPWpGaD
Fludarabine—Decreased appetite—Dactinomycin—uterine cancer	0.000681	0.00149	CcSEcCtD
Fludarabine—Fatigue—Dactinomycin—uterine cancer	0.000675	0.00148	CcSEcCtD
Fludarabine—Pain—Dactinomycin—uterine cancer	0.00067	0.00146	CcSEcCtD
Fludarabine—Hepatic failure—Doxorubicin—uterine cancer	0.000665	0.00145	CcSEcCtD
Fludarabine—RRM1—Integrated Pancreatic Cancer Pathway—ERBB2—uterine cancer	0.000663	0.00241	CbGpPWpGaD
Fludarabine—Cardiac failure—Epirubicin—uterine cancer	0.000662	0.00145	CcSEcCtD
Fludarabine—Cerebrovascular accident—Epirubicin—uterine cancer	0.000659	0.00144	CcSEcCtD
Fludarabine—Cardiac failure congestive—Doxorubicin—uterine cancer	0.000659	0.00144	CcSEcCtD
Fludarabine—Nausea—Progesterone—uterine cancer	0.000658	0.00144	CcSEcCtD
Fludarabine—POLA1—Cell Cycle, Mitotic—POLD1—uterine cancer	0.000657	0.00239	CbGpPWpGaD
Fludarabine—POLA1—E2F transcription factor network—EP300—uterine cancer	0.000656	0.00239	CbGpPWpGaD
Fludarabine—POLA1—Retinoblastoma (RB) in Cancer—CDKN1B—uterine cancer	0.000649	0.00236	CbGpPWpGaD
Fludarabine—Gastrointestinal haemorrhage—Epirubicin—uterine cancer	0.000646	0.00141	CcSEcCtD
Fludarabine—Feeling abnormal—Dactinomycin—uterine cancer	0.000645	0.00141	CcSEcCtD
Fludarabine—Ill-defined disorder—Etoposide—uterine cancer	0.000644	0.00141	CcSEcCtD
Fludarabine—Anaemia—Etoposide—uterine cancer	0.000642	0.0014	CcSEcCtD
Fludarabine—Vomiting—Medroxyprogesterone Acetate—uterine cancer	0.000638	0.0014	CcSEcCtD
Fludarabine—Rash—Medroxyprogesterone Acetate—uterine cancer	0.000633	0.00138	CcSEcCtD
Fludarabine—Dermatitis—Medroxyprogesterone Acetate—uterine cancer	0.000632	0.00138	CcSEcCtD
Fludarabine—Headache—Medroxyprogesterone Acetate—uterine cancer	0.000629	0.00137	CcSEcCtD
Fludarabine—Malaise—Etoposide—uterine cancer	0.000626	0.00137	CcSEcCtD
Fludarabine—Leukopenia—Etoposide—uterine cancer	0.000621	0.00136	CcSEcCtD
Fludarabine—Body temperature increased—Dactinomycin—uterine cancer	0.000619	0.00135	CcSEcCtD
Fludarabine—RRM1—Integrated Pancreatic Cancer Pathway—CDKN1B—uterine cancer	0.000614	0.00224	CbGpPWpGaD
Fludarabine—Cardiac failure—Doxorubicin—uterine cancer	0.000613	0.00134	CcSEcCtD
Fludarabine—Cerebrovascular accident—Doxorubicin—uterine cancer	0.00061	0.00133	CcSEcCtD
Fludarabine—DCK—Metabolism—NDUFB11—uterine cancer	0.000608	0.00221	CbGpPWpGaD
Fludarabine—DCK—Metabolism—SRD5A2—uterine cancer	0.000608	0.00221	CbGpPWpGaD
Fludarabine—Cough—Etoposide—uterine cancer	0.000606	0.00132	CcSEcCtD
Fludarabine—Convulsion—Etoposide—uterine cancer	0.000602	0.00132	CcSEcCtD
Fludarabine—Dehydration—Epirubicin—uterine cancer	0.000601	0.00131	CcSEcCtD
Fludarabine—POLA1—Synthesis of DNA—CDKN1B—uterine cancer	0.0006	0.00218	CbGpPWpGaD
Fludarabine—Gastrointestinal haemorrhage—Doxorubicin—uterine cancer	0.000598	0.00131	CcSEcCtD
Fludarabine—Liver function test abnormal—Epirubicin—uterine cancer	0.000597	0.0013	CcSEcCtD
Fludarabine—Nausea—Medroxyprogesterone Acetate—uterine cancer	0.000596	0.0013	CcSEcCtD
Fludarabine—POLA1—Cell Cycle—POLD1—uterine cancer	0.000588	0.00214	CbGpPWpGaD
Fludarabine—Discomfort—Etoposide—uterine cancer	0.000584	0.00128	CcSEcCtD
Fludarabine—Toxic epidermal necrolysis—Epirubicin—uterine cancer	0.000582	0.00127	CcSEcCtD
Fludarabine—RRM1—Integrated Pancreatic Cancer Pathway—CTNNB1—uterine cancer	0.00058	0.00211	CbGpPWpGaD
Fludarabine—Hypersensitivity—Dactinomycin—uterine cancer	0.000577	0.00126	CcSEcCtD
Fludarabine—RRM1—Metabolism—STAR—uterine cancer	0.000571	0.00208	CbGpPWpGaD
Fludarabine—RRM1—Metabolism—AKR1B1—uterine cancer	0.000571	0.00208	CbGpPWpGaD
Fludarabine—Confusional state—Etoposide—uterine cancer	0.000571	0.00125	CcSEcCtD
Fludarabine—Anaphylactic shock—Etoposide—uterine cancer	0.000567	0.00124	CcSEcCtD
Fludarabine—RRM1—Integrated Pancreatic Cancer Pathway—PTEN—uterine cancer	0.000565	0.00206	CbGpPWpGaD
Fludarabine—Infection—Etoposide—uterine cancer	0.000563	0.00123	CcSEcCtD
Fludarabine—POLA1—DNA Replication—CDKN1B—uterine cancer	0.000563	0.00205	CbGpPWpGaD
Fludarabine—Asthenia—Dactinomycin—uterine cancer	0.000562	0.00123	CcSEcCtD
Fludarabine—Dysphagia—Epirubicin—uterine cancer	0.000559	0.00122	CcSEcCtD
Fludarabine—DCK—Retinoblastoma (RB) in Cancer—TP53—uterine cancer	0.000557	0.00203	CbGpPWpGaD
Fludarabine—Dehydration—Doxorubicin—uterine cancer	0.000556	0.00122	CcSEcCtD
Fludarabine—Thrombocytopenia—Etoposide—uterine cancer	0.000555	0.00121	CcSEcCtD
Fludarabine—Liver function test abnormal—Doxorubicin—uterine cancer	0.000552	0.00121	CcSEcCtD
Fludarabine—POLA1—Cell Cycle, Mitotic—RRM2—uterine cancer	0.000548	0.002	CbGpPWpGaD
Fludarabine—Hyperhidrosis—Etoposide—uterine cancer	0.000548	0.0012	CcSEcCtD
Fludarabine—Angina pectoris—Epirubicin—uterine cancer	0.000544	0.00119	CcSEcCtD
Fludarabine—POLA1—G1/S Transition—CDKN1B—uterine cancer	0.000542	0.00197	CbGpPWpGaD
Fludarabine—Anorexia—Etoposide—uterine cancer	0.00054	0.00118	CcSEcCtD
Fludarabine—RRM1—Integrated Pancreatic Cancer Pathway—EP300—uterine cancer	0.000539	0.00196	CbGpPWpGaD
Fludarabine—Toxic epidermal necrolysis—Doxorubicin—uterine cancer	0.000538	0.00118	CcSEcCtD
Fludarabine—Bronchitis—Epirubicin—uterine cancer	0.000537	0.00117	CcSEcCtD
Fludarabine—Diarrhoea—Dactinomycin—uterine cancer	0.000536	0.00117	CcSEcCtD
Fludarabine—Pancytopenia—Epirubicin—uterine cancer	0.00053	0.00116	CcSEcCtD
Fludarabine—Dysuria—Epirubicin—uterine cancer	0.000522	0.00114	CcSEcCtD
Fludarabine—Neutropenia—Epirubicin—uterine cancer	0.000522	0.00114	CcSEcCtD
Fludarabine—Upper respiratory tract infection—Epirubicin—uterine cancer	0.000519	0.00114	CcSEcCtD
Fludarabine—Dysphagia—Doxorubicin—uterine cancer	0.000517	0.00113	CcSEcCtD
Fludarabine—POLA1—Mitotic G1-G1/S phases—CDKN2A—uterine cancer	0.000516	0.00188	CbGpPWpGaD
Fludarabine—RRM1—Integrated Pancreatic Cancer Pathway—VEGFA—uterine cancer	0.000511	0.00186	CbGpPWpGaD
Fludarabine—POLA1—Integrated Pancreatic Cancer Pathway—ESR1—uterine cancer	0.000509	0.00185	CbGpPWpGaD
Fludarabine—Paraesthesia—Etoposide—uterine cancer	0.000509	0.00111	CcSEcCtD
Fludarabine—Dyspnoea—Etoposide—uterine cancer	0.000505	0.0011	CcSEcCtD
Fludarabine—Hyperglycaemia—Epirubicin—uterine cancer	0.000504	0.0011	CcSEcCtD
Fludarabine—Angina pectoris—Doxorubicin—uterine cancer	0.000503	0.0011	CcSEcCtD
Fludarabine—Pneumonia—Epirubicin—uterine cancer	0.000501	0.0011	CcSEcCtD
Fludarabine—Vomiting—Dactinomycin—uterine cancer	0.000498	0.00109	CcSEcCtD
Fludarabine—Bronchitis—Doxorubicin—uterine cancer	0.000497	0.00109	CcSEcCtD
Fludarabine—Stevens-Johnson syndrome—Epirubicin—uterine cancer	0.000494	0.00108	CcSEcCtD
Fludarabine—Rash—Dactinomycin—uterine cancer	0.000494	0.00108	CcSEcCtD
Fludarabine—Decreased appetite—Etoposide—uterine cancer	0.000493	0.00108	CcSEcCtD
Fludarabine—POLA1—S Phase—CDKN1B—uterine cancer	0.000492	0.00179	CbGpPWpGaD
Fludarabine—Pancytopenia—Doxorubicin—uterine cancer	0.000491	0.00107	CcSEcCtD
Fludarabine—POLA1—Cell Cycle—RRM2—uterine cancer	0.00049	0.00178	CbGpPWpGaD
Fludarabine—Renal failure—Epirubicin—uterine cancer	0.00049	0.00107	CcSEcCtD
Fludarabine—Gastrointestinal disorder—Etoposide—uterine cancer	0.000489	0.00107	CcSEcCtD
Fludarabine—Fatigue—Etoposide—uterine cancer	0.000489	0.00107	CcSEcCtD
Fludarabine—Neuropathy peripheral—Epirubicin—uterine cancer	0.000488	0.00107	CcSEcCtD
Fludarabine—Stomatitis—Epirubicin—uterine cancer	0.000485	0.00106	CcSEcCtD
Fludarabine—Pain—Etoposide—uterine cancer	0.000485	0.00106	CcSEcCtD
Fludarabine—Constipation—Etoposide—uterine cancer	0.000485	0.00106	CcSEcCtD
Fludarabine—Urinary tract infection—Epirubicin—uterine cancer	0.000484	0.00106	CcSEcCtD
Fludarabine—Dysuria—Doxorubicin—uterine cancer	0.000483	0.00106	CcSEcCtD
Fludarabine—Neutropenia—Doxorubicin—uterine cancer	0.000483	0.00106	CcSEcCtD
Fludarabine—Upper respiratory tract infection—Doxorubicin—uterine cancer	0.00048	0.00105	CcSEcCtD
Fludarabine—Haematuria—Epirubicin—uterine cancer	0.000475	0.00104	CcSEcCtD
Fludarabine—Epistaxis—Epirubicin—uterine cancer	0.00047	0.00103	CcSEcCtD
Fludarabine—Sinusitis—Epirubicin—uterine cancer	0.000467	0.00102	CcSEcCtD
Fludarabine—Feeling abnormal—Etoposide—uterine cancer	0.000467	0.00102	CcSEcCtD
Fludarabine—Hyperglycaemia—Doxorubicin—uterine cancer	0.000466	0.00102	CcSEcCtD
Fludarabine—Nausea—Dactinomycin—uterine cancer	0.000465	0.00102	CcSEcCtD
Fludarabine—Pneumonia—Doxorubicin—uterine cancer	0.000463	0.00101	CcSEcCtD
Fludarabine—Stevens-Johnson syndrome—Doxorubicin—uterine cancer	0.000457	0.000999	CcSEcCtD
Fludarabine—POLA1—Mitotic G1-G1/S phases—CDKN1B—uterine cancer	0.000457	0.00166	CbGpPWpGaD
Fludarabine—Renal failure—Doxorubicin—uterine cancer	0.000453	0.000991	CcSEcCtD
Fludarabine—Neuropathy peripheral—Doxorubicin—uterine cancer	0.000452	0.000988	CcSEcCtD
Fludarabine—Haemoglobin—Epirubicin—uterine cancer	0.000449	0.000983	CcSEcCtD
Fludarabine—Stomatitis—Doxorubicin—uterine cancer	0.000449	0.000982	CcSEcCtD
Fludarabine—RRM1—Metabolism—POLD1—uterine cancer	0.000448	0.00163	CbGpPWpGaD
Fludarabine—Body temperature increased—Etoposide—uterine cancer	0.000448	0.000979	CcSEcCtD
Fludarabine—Urinary tract infection—Doxorubicin—uterine cancer	0.000448	0.000979	CcSEcCtD
Fludarabine—Haemorrhage—Epirubicin—uterine cancer	0.000447	0.000978	CcSEcCtD
Fludarabine—Hypoaesthesia—Epirubicin—uterine cancer	0.000445	0.000973	CcSEcCtD
Fludarabine—Pharyngitis—Epirubicin—uterine cancer	0.000444	0.00097	CcSEcCtD
Fludarabine—POLA1—Cell Cycle, Mitotic—YWHAE—uterine cancer	0.00044	0.0016	CbGpPWpGaD
Fludarabine—DCK—Metabolism—AKR1B1—uterine cancer	0.00044	0.0016	CbGpPWpGaD
Fludarabine—DCK—Metabolism—STAR—uterine cancer	0.00044	0.0016	CbGpPWpGaD
Fludarabine—Haematuria—Doxorubicin—uterine cancer	0.000439	0.000961	CcSEcCtD
Fludarabine—POLA1—Cell Cycle—MLH1—uterine cancer	0.000435	0.00158	CbGpPWpGaD
Fludarabine—Epistaxis—Doxorubicin—uterine cancer	0.000435	0.00095	CcSEcCtD
Fludarabine—RRM1—Integrated Pancreatic Cancer Pathway—KRAS—uterine cancer	0.000434	0.00158	CbGpPWpGaD
Fludarabine—Sinusitis—Doxorubicin—uterine cancer	0.000432	0.000945	CcSEcCtD
Fludarabine—Visual impairment—Epirubicin—uterine cancer	0.000431	0.000942	CcSEcCtD
Fludarabine—Erythema multiforme—Epirubicin—uterine cancer	0.000423	0.000924	CcSEcCtD
Fludarabine—RRM1—Metabolism—AKR1C1—uterine cancer	0.000419	0.00153	CbGpPWpGaD
Fludarabine—Hypersensitivity—Etoposide—uterine cancer	0.000417	0.000913	CcSEcCtD
Fludarabine—Haemoglobin—Doxorubicin—uterine cancer	0.000416	0.000909	CcSEcCtD
Fludarabine—Haemorrhage—Doxorubicin—uterine cancer	0.000414	0.000905	CcSEcCtD
Fludarabine—Hypoaesthesia—Doxorubicin—uterine cancer	0.000412	0.0009	CcSEcCtD
Fludarabine—Pharyngitis—Doxorubicin—uterine cancer	0.000411	0.000898	CcSEcCtD
Fludarabine—POLA1—Retinoblastoma (RB) in Cancer—TP53—uterine cancer	0.000408	0.00148	CbGpPWpGaD
Fludarabine—Asthenia—Etoposide—uterine cancer	0.000407	0.000889	CcSEcCtD
Fludarabine—Chills—Epirubicin—uterine cancer	0.000401	0.000877	CcSEcCtD
Fludarabine—Pruritus—Etoposide—uterine cancer	0.000401	0.000877	CcSEcCtD
Fludarabine—Arrhythmia—Epirubicin—uterine cancer	0.000399	0.000873	CcSEcCtD
Fludarabine—RRM1—Integrated Pancreatic Cancer Pathway—PIK3CA—uterine cancer	0.000399	0.00145	CbGpPWpGaD
Fludarabine—Visual impairment—Doxorubicin—uterine cancer	0.000399	0.000872	CcSEcCtD
Fludarabine—Alopecia—Epirubicin—uterine cancer	0.000395	0.000864	CcSEcCtD
Fludarabine—POLA1—Cell Cycle—YWHAE—uterine cancer	0.000394	0.00143	CbGpPWpGaD
Fludarabine—Erythema multiforme—Doxorubicin—uterine cancer	0.000391	0.000855	CcSEcCtD
Fludarabine—Malnutrition—Epirubicin—uterine cancer	0.000389	0.000851	CcSEcCtD
Fludarabine—Diarrhoea—Etoposide—uterine cancer	0.000388	0.000848	CcSEcCtD
Fludarabine—RRM1—Integrated Pancreatic Cancer Pathway—TP53—uterine cancer	0.000386	0.0014	CbGpPWpGaD
Fludarabine—POLA1—Mitotic M-M/G1 phases—BIRC5—uterine cancer	0.000381	0.00139	CbGpPWpGaD
Fludarabine—RRM1—Metabolism—RRM2—uterine cancer	0.000374	0.00136	CbGpPWpGaD
Fludarabine—POLA1—Integrated Pancreatic Cancer Pathway—ERBB2—uterine cancer	0.000373	0.00136	CbGpPWpGaD
Fludarabine—Chills—Doxorubicin—uterine cancer	0.000371	0.000812	CcSEcCtD
Fludarabine—Arrhythmia—Doxorubicin—uterine cancer	0.00037	0.000808	CcSEcCtD
Fludarabine—Alopecia—Doxorubicin—uterine cancer	0.000366	0.000799	CcSEcCtD
Fludarabine—RRM1—Metabolism—DCN—uterine cancer	0.000363	0.00132	CbGpPWpGaD
Fludarabine—Ill-defined disorder—Epirubicin—uterine cancer	0.000361	0.00079	CcSEcCtD
Fludarabine—Vomiting—Etoposide—uterine cancer	0.00036	0.000788	CcSEcCtD
Fludarabine—Malnutrition—Doxorubicin—uterine cancer	0.00036	0.000787	CcSEcCtD
Fludarabine—Anaemia—Epirubicin—uterine cancer	0.00036	0.000787	CcSEcCtD
Fludarabine—Agitation—Epirubicin—uterine cancer	0.000358	0.000782	CcSEcCtD
Fludarabine—Rash—Etoposide—uterine cancer	0.000357	0.000781	CcSEcCtD
Fludarabine—Dermatitis—Etoposide—uterine cancer	0.000357	0.000781	CcSEcCtD
Fludarabine—Headache—Etoposide—uterine cancer	0.000355	0.000776	CcSEcCtD
Fludarabine—Malaise—Epirubicin—uterine cancer	0.000351	0.000767	CcSEcCtD
Fludarabine—Leukopenia—Epirubicin—uterine cancer	0.000348	0.000762	CcSEcCtD
Fludarabine—POLA1—Integrated Pancreatic Cancer Pathway—CDKN1B—uterine cancer	0.000346	0.00126	CbGpPWpGaD
Fludarabine—DCK—Metabolism—POLD1—uterine cancer	0.000345	0.00126	CbGpPWpGaD
Fludarabine—RRM1—Metabolism—CYP11A1—uterine cancer	0.000342	0.00124	CbGpPWpGaD
Fludarabine—Cough—Epirubicin—uterine cancer	0.00034	0.000743	CcSEcCtD
Fludarabine—Convulsion—Epirubicin—uterine cancer	0.000337	0.000737	CcSEcCtD
Fludarabine—Nausea—Etoposide—uterine cancer	0.000337	0.000736	CcSEcCtD
Fludarabine—Ill-defined disorder—Doxorubicin—uterine cancer	0.000334	0.000731	CcSEcCtD
Fludarabine—Anaemia—Doxorubicin—uterine cancer	0.000333	0.000728	CcSEcCtD
Fludarabine—Arthralgia—Epirubicin—uterine cancer	0.000331	0.000725	CcSEcCtD
Fludarabine—Myalgia—Epirubicin—uterine cancer	0.000331	0.000725	CcSEcCtD
Fludarabine—Agitation—Doxorubicin—uterine cancer	0.000331	0.000724	CcSEcCtD
Fludarabine—POLA1—Cell Cycle, Mitotic—CDKN2B—uterine cancer	0.000331	0.0012	CbGpPWpGaD
Fludarabine—Discomfort—Epirubicin—uterine cancer	0.000327	0.000716	CcSEcCtD
Fludarabine—POLA1—Integrated Pancreatic Cancer Pathway—CTNNB1—uterine cancer	0.000327	0.00119	CbGpPWpGaD
Fludarabine—RRM1—Integrated Pancreatic Cancer Pathway—AKT1—uterine cancer	0.000326	0.00119	CbGpPWpGaD
Fludarabine—Malaise—Doxorubicin—uterine cancer	0.000325	0.00071	CcSEcCtD
Fludarabine—RRM1—Metabolism—AKR1C3—uterine cancer	0.000323	0.00118	CbGpPWpGaD
Fludarabine—DCK—Metabolism—AKR1C1—uterine cancer	0.000323	0.00117	CbGpPWpGaD
Fludarabine—Leukopenia—Doxorubicin—uterine cancer	0.000322	0.000705	CcSEcCtD
Fludarabine—Confusional state—Epirubicin—uterine cancer	0.00032	0.0007	CcSEcCtD
Fludarabine—POLA1—Integrated Pancreatic Cancer Pathway—PTEN—uterine cancer	0.000318	0.00116	CbGpPWpGaD
Fludarabine—Oedema—Epirubicin—uterine cancer	0.000318	0.000695	CcSEcCtD
Fludarabine—Anaphylactic shock—Epirubicin—uterine cancer	0.000318	0.000695	CcSEcCtD
Fludarabine—Infection—Epirubicin—uterine cancer	0.000316	0.00069	CcSEcCtD
Fludarabine—Cough—Doxorubicin—uterine cancer	0.000314	0.000687	CcSEcCtD
Fludarabine—Convulsion—Doxorubicin—uterine cancer	0.000312	0.000682	CcSEcCtD
Fludarabine—Nervous system disorder—Epirubicin—uterine cancer	0.000311	0.000681	CcSEcCtD
Fludarabine—Thrombocytopenia—Epirubicin—uterine cancer	0.000311	0.00068	CcSEcCtD
Fludarabine—Hyperhidrosis—Epirubicin—uterine cancer	0.000307	0.000671	CcSEcCtD
Fludarabine—Arthralgia—Doxorubicin—uterine cancer	0.000307	0.00067	CcSEcCtD
Fludarabine—Myalgia—Doxorubicin—uterine cancer	0.000307	0.00067	CcSEcCtD
Fludarabine—POLA1—Integrated Pancreatic Cancer Pathway—EP300—uterine cancer	0.000304	0.00111	CbGpPWpGaD
Fludarabine—Discomfort—Doxorubicin—uterine cancer	0.000303	0.000662	CcSEcCtD
Fludarabine—Anorexia—Epirubicin—uterine cancer	0.000303	0.000662	CcSEcCtD
Fludarabine—Confusional state—Doxorubicin—uterine cancer	0.000296	0.000648	CcSEcCtD
Fludarabine—POLA1—Cell Cycle—CDKN2B—uterine cancer	0.000296	0.00108	CbGpPWpGaD
Fludarabine—Oedema—Doxorubicin—uterine cancer	0.000294	0.000643	CcSEcCtD
Fludarabine—Anaphylactic shock—Doxorubicin—uterine cancer	0.000294	0.000643	CcSEcCtD
Fludarabine—Infection—Doxorubicin—uterine cancer	0.000292	0.000638	CcSEcCtD
Fludarabine—Musculoskeletal discomfort—Epirubicin—uterine cancer	0.000289	0.000633	CcSEcCtD
Fludarabine—Nervous system disorder—Doxorubicin—uterine cancer	0.000288	0.00063	CcSEcCtD
Fludarabine—Thrombocytopenia—Doxorubicin—uterine cancer	0.000288	0.000629	CcSEcCtD
Fludarabine—POLA1—Integrated Pancreatic Cancer Pathway—VEGFA—uterine cancer	0.000288	0.00105	CbGpPWpGaD
Fludarabine—DCK—Metabolism—RRM2—uterine cancer	0.000288	0.00105	CbGpPWpGaD
Fludarabine—POLA1—Cell Cycle, Mitotic—BIRC5—uterine cancer	0.000285	0.00104	CbGpPWpGaD
Fludarabine—Paraesthesia—Epirubicin—uterine cancer	0.000285	0.000624	CcSEcCtD
Fludarabine—Hyperhidrosis—Doxorubicin—uterine cancer	0.000284	0.000621	CcSEcCtD
Fludarabine—Dyspnoea—Epirubicin—uterine cancer	0.000283	0.000619	CcSEcCtD
Fludarabine—Anorexia—Doxorubicin—uterine cancer	0.00028	0.000613	CcSEcCtD
Fludarabine—Dyspepsia—Epirubicin—uterine cancer	0.00028	0.000611	CcSEcCtD
Fludarabine—DCK—Metabolism—DCN—uterine cancer	0.000279	0.00102	CbGpPWpGaD
Fludarabine—Decreased appetite—Epirubicin—uterine cancer	0.000276	0.000604	CcSEcCtD
Fludarabine—Gastrointestinal disorder—Epirubicin—uterine cancer	0.000274	0.0006	CcSEcCtD
Fludarabine—Fatigue—Epirubicin—uterine cancer	0.000274	0.000599	CcSEcCtD
Fludarabine—Constipation—Epirubicin—uterine cancer	0.000272	0.000594	CcSEcCtD
Fludarabine—Pain—Epirubicin—uterine cancer	0.000272	0.000594	CcSEcCtD
Fludarabine—Musculoskeletal discomfort—Doxorubicin—uterine cancer	0.000268	0.000586	CcSEcCtD
Fludarabine—Paraesthesia—Doxorubicin—uterine cancer	0.000264	0.000577	CcSEcCtD
Fludarabine—DCK—Metabolism—CYP11A1—uterine cancer	0.000263	0.000958	CbGpPWpGaD
Fludarabine—Dyspnoea—Doxorubicin—uterine cancer	0.000262	0.000573	CcSEcCtD
Fludarabine—Feeling abnormal—Epirubicin—uterine cancer	0.000262	0.000572	CcSEcCtD
Fludarabine—Dyspepsia—Doxorubicin—uterine cancer	0.000259	0.000566	CcSEcCtD
Fludarabine—Decreased appetite—Doxorubicin—uterine cancer	0.000255	0.000559	CcSEcCtD
Fludarabine—POLA1—Cell Cycle—BIRC5—uterine cancer	0.000255	0.000929	CbGpPWpGaD
Fludarabine—Gastrointestinal disorder—Doxorubicin—uterine cancer	0.000254	0.000555	CcSEcCtD
Fludarabine—Fatigue—Doxorubicin—uterine cancer	0.000253	0.000554	CcSEcCtD
Fludarabine—RRM1—Metabolism—CYP19A1—uterine cancer	0.000252	0.000916	CbGpPWpGaD
Fludarabine—RRM1—Metabolism—STK11—uterine cancer	0.000252	0.000916	CbGpPWpGaD
Fludarabine—Pain—Doxorubicin—uterine cancer	0.000251	0.00055	CcSEcCtD
Fludarabine—Constipation—Doxorubicin—uterine cancer	0.000251	0.00055	CcSEcCtD
Fludarabine—Body temperature increased—Epirubicin—uterine cancer	0.000251	0.000549	CcSEcCtD
Fludarabine—DCK—Metabolism—AKR1C3—uterine cancer	0.000248	0.000904	CbGpPWpGaD
Fludarabine—POLA1—Integrated Pancreatic Cancer Pathway—KRAS—uterine cancer	0.000245	0.00089	CbGpPWpGaD
Fludarabine—Feeling abnormal—Doxorubicin—uterine cancer	0.000242	0.00053	CcSEcCtD
Fludarabine—Hypersensitivity—Epirubicin—uterine cancer	0.000234	0.000512	CcSEcCtD
Fludarabine—Body temperature increased—Doxorubicin—uterine cancer	0.000232	0.000508	CcSEcCtD
Fludarabine—Asthenia—Epirubicin—uterine cancer	0.000228	0.000498	CcSEcCtD
Fludarabine—Pruritus—Epirubicin—uterine cancer	0.000225	0.000491	CcSEcCtD
Fludarabine—POLA1—Integrated Pancreatic Cancer Pathway—PIK3CA—uterine cancer	0.000225	0.000818	CbGpPWpGaD
Fludarabine—POLA1—Integrated Pancreatic Cancer Pathway—TP53—uterine cancer	0.000217	0.000791	CbGpPWpGaD
Fludarabine—Diarrhoea—Epirubicin—uterine cancer	0.000217	0.000475	CcSEcCtD
Fludarabine—Hypersensitivity—Doxorubicin—uterine cancer	0.000217	0.000473	CcSEcCtD
Fludarabine—Asthenia—Doxorubicin—uterine cancer	0.000211	0.000461	CcSEcCtD
Fludarabine—Pruritus—Doxorubicin—uterine cancer	0.000208	0.000455	CcSEcCtD
Fludarabine—Vomiting—Epirubicin—uterine cancer	0.000202	0.000442	CcSEcCtD
Fludarabine—Diarrhoea—Doxorubicin—uterine cancer	0.000201	0.00044	CcSEcCtD
Fludarabine—Rash—Epirubicin—uterine cancer	0.0002	0.000438	CcSEcCtD
Fludarabine—Dermatitis—Epirubicin—uterine cancer	0.0002	0.000438	CcSEcCtD
Fludarabine—Headache—Epirubicin—uterine cancer	0.000199	0.000435	CcSEcCtD
Fludarabine—DCK—Metabolism—STK11—uterine cancer	0.000194	0.000705	CbGpPWpGaD
Fludarabine—DCK—Metabolism—CYP19A1—uterine cancer	0.000194	0.000705	CbGpPWpGaD
Fludarabine—POLA1—Cell Cycle, Mitotic—CDKN2A—uterine cancer	0.000189	0.000688	CbGpPWpGaD
Fludarabine—RRM1—Metabolism—MTHFR—uterine cancer	0.000189	0.000688	CbGpPWpGaD
Fludarabine—Nausea—Epirubicin—uterine cancer	0.000189	0.000413	CcSEcCtD
Fludarabine—Vomiting—Doxorubicin—uterine cancer	0.000187	0.000409	CcSEcCtD
Fludarabine—Rash—Doxorubicin—uterine cancer	0.000185	0.000405	CcSEcCtD
Fludarabine—Dermatitis—Doxorubicin—uterine cancer	0.000185	0.000405	CcSEcCtD
Fludarabine—Headache—Doxorubicin—uterine cancer	0.000184	0.000403	CcSEcCtD
Fludarabine—POLA1—Integrated Pancreatic Cancer Pathway—AKT1—uterine cancer	0.000184	0.000668	CbGpPWpGaD
Fludarabine—Nausea—Doxorubicin—uterine cancer	0.000175	0.000382	CcSEcCtD
Fludarabine—POLA1—Cell Cycle—CDKN2A—uterine cancer	0.000169	0.000615	CbGpPWpGaD
Fludarabine—POLA1—Cell Cycle, Mitotic—CDKN1B—uterine cancer	0.000167	0.00061	CbGpPWpGaD
Fludarabine—POLA1—Cell Cycle—CDKN1B—uterine cancer	0.00015	0.000545	CbGpPWpGaD
Fludarabine—POLA1—Cell Cycle, Mitotic—EP300—uterine cancer	0.000147	0.000535	CbGpPWpGaD
Fludarabine—DCK—Metabolism—MTHFR—uterine cancer	0.000145	0.000529	CbGpPWpGaD
Fludarabine—POLA1—Cell Cycle—EP300—uterine cancer	0.000131	0.000479	CbGpPWpGaD
Fludarabine—RRM1—Metabolism—PTEN—uterine cancer	0.000105	0.000383	CbGpPWpGaD
Fludarabine—RRM1—Metabolism—EP300—uterine cancer	0.0001	0.000365	CbGpPWpGaD
Fludarabine—POLA1—Cell Cycle—TP53—uterine cancer	9.41e-05	0.000342	CbGpPWpGaD
Fludarabine—DCK—Metabolism—PTEN—uterine cancer	8.09e-05	0.000295	CbGpPWpGaD
Fludarabine—DCK—Metabolism—EP300—uterine cancer	7.72e-05	0.000281	CbGpPWpGaD
Fludarabine—RRM1—Metabolism—PIK3CA—uterine cancer	7.42e-05	0.00027	CbGpPWpGaD
Fludarabine—RRM1—Metabolism—AKT1—uterine cancer	6.06e-05	0.000221	CbGpPWpGaD
Fludarabine—DCK—Metabolism—PIK3CA—uterine cancer	5.71e-05	0.000208	CbGpPWpGaD
Fludarabine—DCK—Metabolism—AKT1—uterine cancer	4.66e-05	0.00017	CbGpPWpGaD
